Insiders · Profile

Dunn Edmund

Principal Accounting Officer at Monte Rosa Therapeutics. Filing since 3 Jun 2024. CIK 0001989401

Company

Date

Role

Action

Amount

Of holding

GLUE Monte Rosa Therapeutics, Inc.

4 Mar 2026

Principal Accounting Officer

Sold at will

139

$2.50K

0.6%

GLUE Monte Rosa Therapeutics, Inc.

2 Mar 2026

Principal Accounting Officer

Sold at will

536

$9.38K

2.3%

GLUE Monte Rosa Therapeutics, Inc.

27 Feb 2026

Principal Accounting Officer

Sold at will

25,164

$455.51K

52.6%

GLUE Monte Rosa Therapeutics, Inc.

5 Jan 2026

Principal Accounting Officer

Sold at will

1,039

$15.76K

4.4%

GLUE Monte Rosa Therapeutics, Inc.

3 Jun 2025

Principal Accounting Officer

Sold at will

2,062

$9.17K

8.0%

GLUE Monte Rosa Therapeutics, Inc.

5 Jul 2024

Principal Accounting Officer

Sold at will

1,610

$6.17K

10.4%

GLUE Monte Rosa Therapeutics, Inc.

3 Jun 2024

Principal Accounting Officer

Sold at will

1,207

$4.88K

7.2%

7 decisions on file.